ebolavirus
nonseg
negativesens
rna
virus
nnsv
within
order
mononegaviral
possess
multifunct
virion
protein
major
determin
virul
pathogenesi
indispens
viral
replic
host
innat
immun
evas
function
equival
phosphoprotein
p
mononegavirus
rhabdovirus
paramyxovirus
phosphoryl
p
protein
univers
regard
function
import
howev
regulatori
role
phosphoryl
function
remain
unexplor
identifi
highli
conserv
residu
near
homooligomer
coil
coil
motif
essenti
function
affinitypurif
ms
follow
posttransl
modif
ptm
analysi
predict
phosphoryl
coimmunoprecipit
crosslink
biochem
character
studi
reveal
moder
decreas
capac
oligomer
function
analysi
show
sertoala
substitut
ebola
viru
ebov
affect
ifn
inhibitori
activ
nearli
abolish
ebov
minigenom
activ
coimmunoprecipit
studi
demonstr
lost
interact
amino
terminu
viral
polymeras
viral
nucleoprotein
np
taken
togeth
find
provid
evid
phosphoryl
modul
function
support
nnsv
p
protein
provid
potenti
valuabl
therapeut
target
import
ebola
viru
ebov
caus
sever
diseas
human
west
african
epidem
two
recent
outbreak
democrat
republ
congo
underscor
urgent
need
effect
countermeasur
remain
lack
better
understand
ebov
biolog
modul
multifunct
viral
protein
desper
need
develop
improv
therapeut
provid
evid
function
virion
protein
modul
phosphoryl
conserv
residu
among
ebolaviru
speci
find
shed
light
ebov
biolog
present
potenti
target
broad
act
antiebolaviru
therapeut
ebolavirus
nonseg
negativesens
rna
virus
nnsv
within
order
mononegaviral
possess
multifunct
virion
protein
major
determin
virul
pathogenesi
indispens
viral
replic
host
innat
immun
evas
function
equival
phosphoprotein
p
mononegavirus
rhabdovirus
paramyxovirus
phosphoryl
p
protein
univers
regard
function
import
howev
regulatori
role
phosphoryl
function
remain
unexplor
identifi
highli
conserv
residu
near
homooligomer
coil
coil
motif
essenti
function
affinitypurif
ms
follow
posttransl
modif
ptm
analysi
predict
phosphoryl
coimmunoprecipit
crosslink
biochem
character
studi
reveal
moder
decreas
capac
oligomer
function
analysi
show
sertoala
substitut
ebola
viru
ebov
affect
ifn
inhibitori
activ
nearli
abolish
ebov
minigenom
activ
coimmunoprecipit
studi
demonstr
lost
interact
amino
terminu
viral
polymeras
viral
nucleoprotein
np
taken
togeth
find
provid
evid
phosphoryl
modul
function
support
nnsv
p
protein
provid
potenti
valuabl
therapeut
target
suppress
also
function
essenti
cofactor
viral
rnadepend
rna
polymeras
name
l
larg
polymeras
protein
function
viral
polymeras
complex
compris
nucleoprotein
np
addit
l
muhlberg
et
yambukumayinga
strain
construct
previous
report
canna
et
al
substitut
introduc
plasmid
use
quikchang
mutagenesi
kit
follow
manufactur
instruct
agil
technolog
inc
santa
clara
ca
primer
sequenc
revers
pcaggshaebovnp
purchas
bei
vector
gener
usamriid
oxid
methionin
includ
variabl
modif
carbamidomethyl
cystein
set
fix
modif
precursor
mass
toler
threshold
set
ppm
maximum
fragment
mass
error
da
qualit
analysi
perform
use
peak
softwar
signific
threshold
ion
score
calcul
base
fals
discoveri
rate
hela
cell
cell
transfect
indic
plasmid
use
transfect
reagent
jetprim
polyplu
per
dna
per
manufactur
instruct
total
amount
dna
transfect
kept
constant
experi
complement
empti
vector
twentyfour
h
posttransfect
cell
lyse
modifi
ripa
buffer
mm
trishcl
ph
mm
nacl
edta
nadeoxychol
contain
proteas
phosphatas
inhibitor
cocktail
thermo
scientif
waltham
usa
approxim
wcl
reserv
ib
analysi
perform
coip
immunoprecipit
indic
protein
lysat
incub
ezview
red
flag
affin
gel
sigma
ezview
red
antiha
affin
gel
sigma
h
bead
wash
time
tb
resuspend
lane
marker
reduc
sampl
buffer
thermo
scientif
subject
sdspage
immunoblot
indic
cell
lysat
subject
reduc
sdspage
protein
transfer
onto
pvdf
membran
blot
probe
indic
primari
antibodi
either
h
rt
overnight
secondari
incub
perform
h
rt
use
either
goat
antirabbit
hrp
goat
antimous
hrp
radianc
chemiluminesc
substrat
azur
biosystem
dublin
ca
usa
use
visual
protein
azur
imag
system
hela
cell
transfect
plasmid
previous
indic
hour
protein
purifi
affin
ml
complet
histag
purif
column
roch
sizeexclus
superos
gl
ge
healthcar
column
respect
nanodsf
perform
use
prometheu
nt
supplement
fetal
bovin
serum
seed
plate
pretreat
polydlysin
hydrobromid
h
h
cell
transfect
ng
plasmid
vector
control
vc
use
lipofectamin
transfect
reagent
per
manufactur
instruct
twentyfour
h
transfect
cell
stimul
ng
iavrna
premix
transfect
reagent
reduc
serum
medium
optimem
incub
hour
co
total
rna
extract
transfect
cell
reagent
invitrogen
rna
revers
transcrib
amplifi
use
luna
univers
onestep
rtqpcr
kit
new
reserv
repres
replic
subject
immunoblot
describ
account
potenti
differ
transfect
effici
firefli
luciferas
activ
normal
renilla
luciferas
valu
plot
fold
activ
calcul
rel
l
control
mean
standard
error
mean
sem
valu
pair
twotail
test
calcul
use
graphpad
prism
softwar
ebov
homooligomer
domain
contain
put
regulatori
serin
phosphoryl
site
given
analog
phosphoprotein
rhabdovirus
paramyxovirus
first
sought
examin
ebov
site
phosphoryl
mass
spectrometri
ms
affinitytag
overexpress
hela
cell
isol
immunoaffin
purif
among
predict
phosphoryl
site
identifi
ms
analysi
chosen
evalu
regulatori
phosphoryl
function
due
posit
lie
outsid
coiledcoil
region
respons
homooligomer
figur
c
moreov
multipl
sequenc
align
ebolaviru
speci
reveal
conserv
among
ebolaviru
speci
except
bomv
figur
bomv
newli
identifi
ebolaviru
speci
yet
shown
pathogen
human
ebolavirus
except
restv
pathogen
human
thu
reason
conserv
may
function
import
accordingli
hypothes
play
import
regulatori
role
nnsv
p
protein
moder
diminish
oligomer
capac
impact
abil
oligomer
use
nonphosphoryl
mimic
gener
alanin
substitut
first
evalu
abil
interact
hela
cell
transfect
alon
combin
h
protein
extract
immunoprecipit
ip
use
antiflag
bead
perform
ip
sampl
whole
cell
lysat
wcl
subject
sdspage
product
analyz
immunoblot
expect
shown
pull
presenc
demonstr
specif
bind
figur
top
panel
similarli
also
pull
presenc
indic
mutant
retain
abil
selfassoci
appropri
protein
express
confirm
wcl
analysi
figur
bottom
panel
next
evalu
oligomer
abil
perform
crosslink
experi
along
seri
biochem
studi
separ
express
hela
cell
h
follow
crosslink
dithiobi
succinimidylpropion
dsp
oligomer
form
analyz
immunoblot
nonreduc
unboil
condit
crosslink
dsp
mark
increas
higher
oligomer
form
well
modest
decreas
monomer
form
rel
dsp
treat
isol
figur
notabl
though
crosslink
result
modest
reduct
format
higher
oligomer
form
compar
wt
indic
decreas
still
oligomer
residu
wt
oligomer
domain
elut
one
distinct
peak
averag
molecular
mass
kda
respect
figur
correspond
roughli
fold
stoichiometri
compar
monomer
molecular
weight
mass
consist
presenc
homotetram
solut
wt
wonder
defect
oligomer
phenotyp
observ
crosslink
immunoblot
due
differ
stabil
tetramer
oligomer
domain
wt
mutant
address
question
perform
thermal
stabil
analysi
miniatur
differenti
scan
fluorimetri
nanodsf
shown
thermal
denatur
curv
wt
oligomer
domain
display
melt
temperatur
tm
valu
respect
figur
although
inflect
point
reminisc
stabl
tertiari
structur
lower
tm
display
mutant
suggest
higher
degre
flexibl
exist
level
oligomer
domain
ccbync
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
therefor
order
assess
mutat
could
caus
structur
perturb
suffici
local
affect
oligomer
domain
fold
test
circular
dichroism
cd
spectroscopi
agreement
previous
observ
wt
oligomer
domain
luthra
et
al
zinzula
et
al
cd
spectra
mutant
typic
protein
mainli
consist
helic
moreov
valu
nm
ellipt
ratio
close
protein
three
temperatur
valu
test
indic
coiledcoil
motif
helic
interactremain
place
mutant
howev
differ
ellipt
profil
suggest
mutat
introduc
local
conform
chang
figur
consist
hypothesi
deconvolut
cd
spectra
analysi
secondari
structur
content
show
oligomer
domain
lower
helic
percentag
respect
wt
temperatur
valu
test
content
diminish
temperatur
increas
figur
result
indic
flexibl
relax
conform
appli
level
coiledcoil
superhelix
upon
substitut
sertoala
residu
investig
effect
oligomer
domain
conform
comput
model
start
avail
wt
crystal
structur
sertoala
substitut
made
oligomer
domain
subject
energi
minim
result
structur
compar
wt
figur
b
conform
unaffect
caus
loss
hydrogen
bond
neighbor
figur
implic
biolog
effect
may
contribut
proteinprotein
interact
modulatori
phosphoryl
figur
taken
togeth
data
indic
reduc
capac
oligomer
rel
suggest
biolog
effect
assess
role
function
examin
ifn
antagonist
function
includ
inhibit
impact
rigimedi
signal
cascad
subsequ
impair
interferon
stimulatedgen
isg
express
use
luciferas
report
gene
assay
first
evalu
inhibit
dsrnainduc
rigi
activ
promot
hek
cell
cotransfect
prltk
variou
dilut
vector
control
twentyfour
h
posttransfect
cell
stimul
influenza
viru
iav
rna
h
report
activ
measur
assess
ifn
inhibit
promot
activ
significantli
inhibit
compar
effici
figur
next
test
effect
express
isg
upon
stimul
viral
rna
poli
c
use
qpcr
analyz
gene
express
two
well
character
isg
oligoadenyl
synthetas
oa
express
isg
induc
stimul
vrna
significantli
reduc
presenc
either
rel
vector
control
specif
express
inhibit
oa
express
inhibit
figur
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
abl
inhibit
protein
express
level
compar
nonstimul
vector
control
figur
collect
data
show
retain
ifn
antagonist
activ
indic
impact
ifn
antagonist
function
abrog
ebov
minigenom
activ
interact
l
sinc
essenti
polymeras
cofactor
next
evalu
effect
ebov
minigenom
activ
plasmid
encod
ebov
minigenom
assay
compon
np
l
minigenom
along
renilla
luciferas
control
transfect
effici
variabl
cotransfect
hela
cell
fortyeight
h
transfect
dualluciferas
assay
use
measur
report
activ
notabl
presenc
nearli
abolish
minigenom
activ
rel
activ
level
close
l
control
figur
addit
repres
lysat
minigenom
assay
subject
immunoblot
confirm
appropri
express
wt
mutant
figur
predominantli
express
one
major
speci
migrat
kd
band
observ
specif
contain
modest
upper
band
kd
kd
wherea
contain
modest
lower
band
kd
may
repres
differenti
ptm
differ
phosphoryl
state
overal
data
suggest
impact
transcript
replic
function
investig
role
replic
function
next
examin
whether
retain
abil
interact
np
l
coip
experi
hela
alon
keep
total
dna
amount
constant
h
protein
harvest
appli
ip
use
hatag
bead
ip
wcl
ip
sampl
subject
sdspage
product
analyz
immunoblot
pull
presenc
hanp
demonstr
specif
interact
indic
retain
abil
interact
np
figur
notabl
wt
pull
hal
wherea
indic
substitut
ala
result
loss
interact
figur
collect
data
show
sertoala
substitut
residu
abolish
minigenom
activ
loss
interact
l
affect
ifn
antagonist
function
effect
uncoupl
ifn
antagonist
replic
function
first
report
suggest
phosphoryl
contribut
regulatori
role
function
present
potenti
therapeut
target
highli
phosphoryl
protein
nnsv
gener
p
protein
phosphoryl
univers
regard
import
p
protein
function
phosphoryl
shown
modul
function
sever
nnsv
includ
vsv
rsv
chpv
bdv
rabv
rpv
mv
muv
ndv
evid
support
lack
filovirus
chattopadhyay
banerje
barik
banerje
barik
banerje
barik
banerje
gao
combin
cellbiolog
biochem
comput
studi
describ
suggest
phosphoryl
play
modulatori
role
ebov
function
thu
support
phosphoryl
ebov
p
protein
function
signific
specif
identifi
highli
conserv
key
regulatori
residu
show
ala
substitut
import
replic
function
ifn
antagonist
function
nanodsf
result
indic
mutant
possess
higher
degre
flexibl
level
oligomer
domain
secondari
structur
content
analysi
indic
flexibl
relax
conform
appli
level
coiledcoil
superhelix
show
interact
np
remain
intact
exhibit
impair
abil
interact
viral
polymeras
shown
vsv
p
protein
must
undergo
phosphorylationdepend
homooligomer
becom
transcript
activ
gao
lenard
consist
find
nanodsf
result
studi
indic
mutant
possess
higher
degre
flexibl
level
oligomer
domain
sever
decreas
ebov
minigenom
activ
addit
oligomer
domain
muv
p
protein
shown
enhanc
effect
pl
interact
support
find
choudhari
et
al
pickar
et
al
shown
phosphoryl
vitro
suggest
possibl
function
may
modul
kinas
prin
et
al
case
exert
ifnantagonist
function
prevent
andor
activ
yet
determin
whether
becom
phosphoryl
infect
cell
though
whether
modul
function
extent
phosphoryl
kinas
ebovinfect
cell
would
influenc
extent
act
decoy
substrat
rel
extent
mere
prevent
kinas
activ
via
steric
inhibit
prin
et
al
even
studi
mutant
impair
replic
function
affect
ifn
antagonist
function
given
high
virul
ebov
infect
multifunct
natur
seem
unlik
phosphoryl
would
detriment
affect
viru
ccbync
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
demonstr
retain
capac
oligomer
level
near
wt
hela
cell
transfect
twentyfour
h
transfect
cell
left
untreat
treat
mm
dsp
asterisk
denot
oligomer
form
c
quaternari
structur
analysi
ebov
oligomer
domain
compar
sampl
annot
f
secondari
structur
content
analysi
ebov
oligomer
domain
cd
spectra
deconvolut
continl
method
structur
composit
helic
indic
percentag
entir
amino
acid
sequenc
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
stimul
presenc
vc
wt
plasmid
transfect
ng
vc
wt
plasmid
twentyfour
h
transfect
cell
stimul
ng
iavrna
h
total
rna
extract
revers
transcrib
subject
quantit
realtim
pcr
rtqpcr
analysi
oligoadenyl
synthetas
oa
level
mrna
express
level
normal
level
dehydrogenas
gapdh
data
repres
mean
sd
two
independ
experi
c
effect
express
upon
poli
c
stimul
hela
cell
left
untransfect
transfect
twentyfour
h
transfect
cell
left
untreat
treat
poli
c
h
cell
harvest
subject
immunoblot
data
repres
mean
sd
p
p
p
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
